MHA Statement on Approval of Johnson & Johnson COVID-19 Vaccine

MHA CEO Brian Peters

The following statement can be attributed to Brian Peters, CEO of the Michigan Health & Hospital Association. 

MHA CEO Brian PetersThe approval of an emergency use authorization for the Johnson & Johnson COVID-19 vaccine is another significant step toward ending the pandemic. The availability of a safe and effective single-dose vaccine will help Michigan vaccinate our population, especially those vulnerable and harder to reach residents, more quickly. The Johnson & Johnson vaccine demonstrated complete protection against COVID-19-related hospitalization and death 28 days post-vaccination in its clinical trials. The addition of a third approved vaccine will also help alleviate existing vaccine supply constraints and quicken the pace of administering vaccines.

Hospitals will continue to assist with vaccination efforts as more details are released by federal and state entities about how this new vaccine should be put to use.